on 20 Jun 2019
TM5 Status
LIVE/REGISTRATION/Issued and Active
Your registration has been issued and is active. You can now use the TM5 mark.
Last Applicant/ Owned by
ALNYLAM PHARMACEUTICALS INC.
300 Third StreetCambridge, MA 02142
US
Serial Number
1793705 filed on 29th Jul 2016
Registration Number
TMA1029292 registered on 20th Jun 2019
Registration expiry Date
20th Jun 2029Correspondent Address
MACRAE & CO.
326 Somerset Street WestOttawa
ONTARIO
CA
K2P0J9
Trademark usage description
pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; pharmaceutical preparations for the treatment of familial amyloid Read More10
1793705
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 50 on 1st Dec 2017 | Allowed |
Submitted for opposition 51 on 1st Dec 2017 | Allowance Notice Sent |
Submitted for opposition 42 on 16th Aug 2017 | Advertised |
Submitted for opposition 26 on 27th Jul 2017 | Approved |
Submitted for opposition 27 on 7th Jun 2017 | Approval Notice Sent |
Submitted for opposition 22 on 17th Feb 2017 | Search Recorded |
Submitted for opposition 20 on 17th Feb 2017 | Examiner's First Report |
Submitted for opposition 31 on 4th Aug 2016 | Formalized |
Submitted for opposition 30 on 29th Jul 2016 | Filed |
Submitted for opposition 1 on 29th Jul 2016 | Created |